Development and Validation of a Risk Score Predicting Medication Non-adherence in Patients with Heart Failure

In this study, we aimed to develop a clinically applicable risk score using demographic and clinical data available at hospital admission for decompensated heart failure (HF) to identify patients at high risk of medication non-adherence after discharge. In total, 795 patients with HF were enrolled from a prospective, multicenter cohort study. A logistic regression model identified independent predictors of medication non-adherence leading to hospitalization, and we derived a risk score from the partial regression coefficients of these factors. Hospitalization due to medication non-adherence occurred in 6.4% of patients. Independent predictors included dementia (odds ratio [OR]: 2.79; 95% confidence interval [CI]: 1.38-5.65), male sex (OR: 2.50; 95% CI: 1.30-4.79), current smoking (OR: 2.17; 95% CI: 1.07-4.41), non-assisted living (OR: 2.14; 95% CI: 1.17-3.94), and prior HF hospitalization (OR: 1.91; 95% CI: 1.05-3.46). The predictive model showed good discrimination (area under the receiver operating characteristic curve = 0.704). Patients with higher risk scores (4-6 points) had significantly higher rates of all-cause and cardiovascular mortality over 2 years. In conclusion, this pragmatic, admission-based risk score enables early identification of patients at risk for medication non-adherence and may support targeted interventions to improve long-term HF outcomes. Incorporating this score into routine admission processes may help prioritize adherence support for high-risk patients, guide multidisciplinary care planning, and reduce post-discharge complications in HF management.

Authors

Institutions

Publication Details

Journal
Biological and Pharmaceutical Bulletin
Published
2026-02-17
DOI
https://doi.org/10.1248/bpb.b25-00611
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development and Validation of a Risk Score Predicting Medication Non-adherence in Patients with Heart Failure

Moemi Okazaki, Kohei Jobu, Yayoi Kawano, Yuki Hyohdoh et al.
Biological and Pharmaceutical Bulletin
Heart Failure Treatment and Management
article

Development and Validation of a Risk Score Predicting Medication Non-adherence in Patients with Heart Failure

Moemi Okazaki, Kohei Jobu, Yayoi Kawano, Yuki Hyohdoh, Eisuke Yamada, Yukihiro Hamada, Takaya Sagawa, K Kawai, H Kitaoka, Yoko Nakaoka, Tomoaki Ishida, Tomoyuki Hamada, Toru Kubo, Takashi Furuno, Kei Kawada, Toshikazu Yabe
article en

Abstract

In this study, we aimed to develop a clinically applicable risk score using demographic and clinical data available at hospital admission for decompensated heart failure (HF) to identify patients at high risk of medication non-adherence after discharge. In total, 795 patients with HF were enrolled from a prospective, multicenter cohort study. A logistic regression model identified independent predictors of medication non-adherence leading to hospitalization, and we derived a risk score from the partial regression coefficients of these factors. Hospitalization due to medication non-adherence occurred in 6.4% of patients. Independent predictors included dementia (odds ratio [OR]: 2.79; 95% confidence interval [CI]: 1.38-5.65), male sex (OR: 2.50; 95% CI: 1.30-4.79), current smoking (OR: 2.17; 95% CI: 1.07-4.41), non-assisted living (OR: 2.14; 95% CI: 1.17-3.94), and prior HF hospitalization (OR: 1.91; 95% CI: 1.05-3.46). The predictive model showed good discrimination (area under the receiver operating characteristic curve = 0.704). Patients with higher risk scores (4-6 points) had significantly higher rates of all-cause and cardiovascular mortality over 2 years. In conclusion, this pragmatic, admission-based risk score enables early identification of patients at risk for medication non-adherence and may support targeted interventions to improve long-term HF outcomes. Incorporating this score into routine admission processes may help prioritize adherence support for high-risk patients, guide multidisciplinary care planning, and reduce post-discharge complications in HF management.

Biological and Pharmaceutical BulletinVol. 49(2)
Suzuki (Japan) (JP), Nagoya City University (JP), Kochi Medical School Hospital (JP), Chikamori Hospital (JP), Kochi Prefectural Education Center (JP), Oida Hospital (JP), Kōchi University (JP), Tokushima University (JP)
Openalex Percentile: Top 55%
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.